Theravance Biopharma (TBPH) Change in Inventory (2013 - 2018)

Theravance Biopharma (TBPH) has reported Change in Inventory for 6 consecutive years, with $1.1 million the latest figure, recorded in Q4 2018.

• In Q4 2018, Change in Inventory fell 75.17% year-over-year to $1.1 million; the TTM figure through Dec 2018 stood at $1.6 million (down 77.69% YoY), while the FY2018 annual figure was $1.6 million, down 77.69% from the prior year.
• Change in Inventory rose to $1.1 million in Q4 2018 per TBPH's latest filing, from $201000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $4.3 million in Q4 2017 and bottomed at -$912000.0 in Q4 2015.
• Historically, Change in Inventory has averaged $885500.0 across 5 years, with a median of $306000.0 in 2015.
• Annual changes were most pronounced in 2014 — Change in Inventory jumped 7096.15% — and 2015, when it sank 542.72%.
• Theravance Biopharma's Change in Inventory stood at $206000.0 in 2014, then tumbled by 542.72% to -$912000.0 in 2015, then surged by 247.37% to $1.3 million in 2016, then jumped by 222.77% to $4.3 million in 2017, then tumbled by 75.17% to $1.1 million in 2018.
• Business Quant data shows TBPH's Change in Inventory at $1.1 million in Q4 2018, $201000.0 in Q3 2018, and -$20000.0 in Q2 2018.